News
Asbestos Laws in Pennsylvania
Asbestos was once widely used in building materials for its durability and heat resistance. However, it’s now known to be extremely hazardous to human health. Inhalation of asbestos fibers can lead to serious diseases such as asbestosis, lung cancer, and mesothelioma. As a result, strict regulations exist at both the federal and state levels to…
Read MorePennsylvania Supreme Court Ruling Opens Door to Mesothelioma Claims Against Employers Beyond Statutory Limits
In a major victory for asbestos victims and their families, the Pennsylvania Supreme Court recently issued a powerful 5-2 opinion affirming the right of workers suffering from long-latency occupational diseases—such as mesothelioma—to pursue legal action against their employers even after the statutory limits of the state’s Occupational Disease Act (ODA) have passed. The decision marks…
Read MoreHomer City Power Station Demolished
On March 22, 2025, the smokestacks and cooling towers of the Homer City Power Station in Indiana County came crashing down in a planned implosion. The demolition marked the physical end of the coal-fired power plant, which had ceased operations in 2023 due to economic pressures and shifting energy trends. While many viewed the event…
Read MoreUnderstanding the FDA’s Proposed Asbestos Testing Rule for Talc-Containing Products
The U.S. Food and Drug Administration (FDA) has recently proposed a new rule aimed at protecting consumers from potential asbestos contamination in talc-containing cosmetic products. This initiative comes in response to growing concerns over the risks associated with asbestos exposure and its link to various health complications, including cancer. With the FDA’s proposed standardized testing…
Read MoreKeytruda’s New FDA Approval for Mesothelioma: A Breakthrough in Treatment
The U.S. Food and Drug Administration (FDA) has recently expanded the use of Keytruda (pembrolizumab), an immunotherapy drug, marking a significant advancement in the treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM). Approved on September 17, 2024, the combination of Keytruda with pemetrexed and platinum-based chemotherapy offers new hope to mesothelioma patients, who…
Read More